Tu J - Search Results

1

Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients.

Huang Y, Li S, Huang S, Tu J, Chen X, Xiao L, Liu B, Yuan X. Huang Y, et al. Among authors: tu j. Front Bioeng Biotechnol. 2022 Jan 26;10:780751. doi: 10.3389/fbioe.2022.780751. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35155389 Free PMC article.

2

Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy.

Tu J, Tu K, Xu H, Wang L, Yuan X, Qin X, Kong L, Chu Q, Zhang Z. Tu J, et al. Among authors: tu k. Eur J Pharm Biopharm. 2020 May;150:96-107. doi: 10.1016/j.ejpb.2020.03.003. Epub 2020 Mar 6. Eur J Pharm Biopharm. 2020. PMID: 32151726

3

Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells.

Tu J, Xu H, Ma L, Li C, Qin W, Chen X, Yi M, Sun L, Liu B, Yuan X. Tu J, et al. Theranostics. 2022 Jan 1;12(2):747-766. doi: 10.7150/thno.65828. eCollection 2022. Theranostics. 2022. PMID: 34976211 Free PMC article.

4

Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma.

Chen X, Tu J, Ma L, Huang Y, Yang C, Yuan X. Chen X, et al. Among authors: tu j. Int J Gen Med. 2022 Mar 19;15:3215-3235. doi: 10.2147/IJGM.S354682. eCollection 2022. Int J Gen Med. 2022. PMID: 35342303 Free PMC article.

5

Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.

Chen X, Wang L, Tu J, Pan X, Li Y, Yin H, Wang M, Yuan X. Chen X, et al. Among authors: tu j. Crit Rev Eukaryot Gene Expr. 2022;32(1):79-98. doi: 10.1615/CritRevEukaryotGeneExpr.2021039325. Crit Rev Eukaryot Gene Expr. 2022. PMID: 35377983

6

MicroRNA-621 functions as a metastasis suppressor in colorectal cancer by directly targeting LEF1 and suppressing Wnt/β-catenin signaling.

Chen X, Tu J, Liu C, Wang L, Yuan X. Chen X, et al. Among authors: tu j. Life Sci. 2022 Nov 1;308:120941. doi: 10.1016/j.lfs.2022.120941. Epub 2022 Sep 7. Life Sci. 2022. PMID: 36087740

7

PLGA Nanoparticles Loaded with Sorafenib Combined with Thermosensitive Hydrogel System and Microwave Hyperthermia for Multiple Sensitized Radiotherapy.

Wang Z, Liu B, Tu J, Xiang J, Xiong H, Wu Y, Ding S, Zhu D, Zhu D, Liu F, Hu G, Yuan X. Wang Z, et al. Among authors: tu j. Pharmaceutics. 2023 Feb 1;15(2):487. doi: 10.3390/pharmaceutics15020487. Pharmaceutics. 2023. PMID: 36839808 Free PMC article.

8

Combining radiation and the ATR inhibitor berzosertib activates STING signaling and enhances immunotherapy via inhibiting SHP1 function in colorectal cancer.

Liu C, Wang X, Qin W, Tu J, Li C, Zhao W, Ma L, Liu B, Qiu H, Yuan X. Liu C, et al. Among authors: tu j. Cancer Commun (Lond). 2023 Apr;43(4):435-454. doi: 10.1002/cac2.12412. Epub 2023 Feb 28. Cancer Commun (Lond). 2023. PMID: 36855844 Free PMC article.

9

Identification and in vitro and in vivo validation of the key role of GSDME in pyroptosis-related genes signature in hepatocellular carcinoma.

Chen X, Yang M, Wang L, Wang Y, Tu J, Zhou X, Yuan X. Chen X, et al. Among authors: tu j. BMC Cancer. 2023 May 6;23(1):411. doi: 10.1186/s12885-023-10850-1. BMC Cancer. 2023. PMID: 37149620 Free PMC article.

10

The application and research progress of anti-angiogenesis therapy in tumor immunotherapy.

Tu J, Liang H, Li C, Huang Y, Wang Z, Chen X, Yuan X. Tu J, et al. Front Immunol. 2023 Jun 2;14:1198972. doi: 10.3389/fimmu.2023.1198972. eCollection 2023. Front Immunol. 2023. PMID: 37334350 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,745 results

Search Page

Filters